SCHEMBL13258951

SCHEMBL13258951

COC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(-c2ccc(-c3cnc([C@@H]4CCCN4C(=O)C(C)C)[nH]3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.67
CYP2C9 P11712 7/20 0.67
KCNH2 Q12809 3/20 0.67
NR1I2 O75469 2/20 0.67
ABCB11 O95342 1/20 0.67
OPRK1 P41145 1/20 0.67
CYP1A2 P05177 3/20 0.60
CYP2D6 P10635 3/20 0.60
PRCP P42785 4/20 0.44
CYP2C19 P33261 3/20 0.43
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10092513 0.98 CYP3A4 (0.69) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10092450 0.94 CYP3A4 (0.58) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10024947 0.93 CYP3A4 (0.79) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL12067474 0.92 CYP3A4 (0.61) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL2707515 0.91 CYP3A4 (0.82) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL2706570 0.91 CYP3A4 (0.82) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL18462834 0.91 CYP3A4 (0.82) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL207039 0.91 CYP3A4 (0.82) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL206808 0.91 CYP3A4 (0.82) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10092462 0.90 CYP3A4 (0.58) CYP3A4CYP2C9KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010096777-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2010-08-26 WO disclosed